European Multidisciplinary Conference in Thoracic Oncology 2013

Oncology Meeting Resources

09 May - 11 May, Lugano, Switzerland

EMCTO 2013

Please find below the links to all EMCTO 2013 presentations that have an abstract, slide set or webcast. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Search Meeting Resources by Keyword

 

 

Useful links

Presenter Presentation title Session title
Keith Kerr Molecular characteristics of lung adenocarcinoma Molecular pathology of non-small cell lung cancer
Martin Edelman Molecular characteristics of lung squamous cell carcinoma Molecular pathology of non-small cell lung cancer
Christophe Dooms Getting tissue in the era of molecular treatment Diagnostic work-up
Malene Fischer PET-CT for lung nodules: Opportunities and pitfalls Diagnostic work-up
Sara Ramella When to treat without tissue confirmation Diagnostic work-up
David R. Jones Reliable lung nodule identification during VATS Diagnostic work-up
Rolf A. Stahel Lungscape Society Symposium: European Thoracic Oncology Platform (ETOP)
Rafael Rosell Belief Society Symposium: European Thoracic Oncology Platform (ETOP)
Solange Peters Emphasis Society Symposium: European Thoracic Oncology Platform (ETOP)
Solange Peters Emerging projects Society Symposium: European Thoracic Oncology Platform (ETOP)
Christopher Croot Effect of enobosarm, a selective androgen receptor modulator, in non-small cell lung cancer (NSCLC) patients with muscle wasting in a phase IIB trial Biology and targeted therapy
Andrew Makin Small cell lung cancer and hyponatremia: interim results from a prospective, observational, global registry Biology and targeted therapy
Thierry Berghmans Discussant Biology and targeted therapy
Alessia Pochesci Reversible epidermal growth factor receptor tyrosine kinases inhibitors (rEGFR-TKIs), erlotinib or gefitinib, compared to chemotherapy (CHT) in previously treated metastatic non small cell lung cancer (NSCLC) patients (pts): a meta-analysis Biology and targeted therapy
Eduardo Castañón Alvarez Impact of EGFR status on the presence of liver metastases (LM) from non-small cell lung cancer (NSCLC) and survival implications Biology and targeted therapy